Yangbing Zhao

Yangbing Zhao is a pioneering researcher in CAR-T cell engineering at the University of Pennsylvania with expertise in EGFR-targeted therapies for solid tumors. His laboratory has developed innovative approaches to improve CAR-T cell function and persistence in the hostile solid tumor microenvironment. He has made important contributions to CAR-T manufacturing optimization and vector design. His preclinical and clinical work has advanced EGFR CAR-T as a viable strategy for lung and other solid cancers.